@article{10.11648/j.sjcm.20150404.12,
  author = {Bâ Hamidou Oumar and Menta Ichaka and Maiga Asmaou Kéita and Daou Adama and Diall Ilo Bella and Coulibaly Souleymane and Doumbia Coumba Thiam and Daffé Sanoussi and Sidibé Noumou and Sangaré Ibrahima and Millogo Georges Rosario Christian and Touré Mamadou and Sidibé Salimata and Diarra Mamadou Bocary},
  title = {Prevalence of Hyperuricemia (HU) in Arterial Hypertension},
  journal = {Science Journal of Clinical Medicine},
  volume = {4},
  number = {4},
  pages = {76-79},
  doi = {10.11648/j.sjcm.20150404.12},
  url = {https://doi.org/10.11648/j.sjcm.20150404.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjcm.20150404.12},
  abstract = {Introduction: Hyperuricemia constitutes a risk for many organs and its prevalence is high ranging from 15-20% up to 35% in developing countries. HU relation to arterial hypertension was pointed out in the end of the XIX century and is recognized as independent cardiovascular risk factor. Thus HU is less studied in our environment which justifies our work to determine prevalence and with HU associated factors among hypertensive patients followed in the Cardiology department in the Mother Child Hospital “Le Luxembourg”. Methodology: It’s was a cross-sectional study in the Mother-Child Hospital “Le Luxembourg” in Bamako. All patients with complete labor tests were included making a sample of 51 hypertensive outpatients seen from July 2010 to January 2011. For any included patient, socio-demographic and biological variables were collected. In the same way a chest radiography, an ECG and an echocardiography were realized. Patients were asked about their knowledge about HU Hyperuricemia was defined as an uricemia > 420 μmol/l for men and 360 μmol/l for women. Microsoft Excel 2007 was used to gather data and SPSS version 12 to perform analyzes. Results: Mean age of the sample was 56,35 years, the sex-ratio Male: Female 0,76. Hyperuricemia, hypercreatininemia and hyperglycemia were found respectively in 66,7,33,3% and 23,5% of the cases. 78,4% of the patients had stated to have heard about hyperuricemia, 27,5% knew their hyperuricemia. The socio-demographic characteristics did not present a statistically significant difference. Conclusion: Hyperuricemia as a cardiovascular risk factor, had to be researched and managed more agressively. The very high proportion of patients with a hyperuricemia requires to detect it among hypertensive patients, to carry out an early treatment and thus to reduce the cardiovascular risk of the patient.},
 year = {2015}
}

Copy | Download

TY  - JOUR
T1  - Prevalence of Hyperuricemia (HU) in Arterial Hypertension
AU  - Bâ Hamidou Oumar
AU  - Menta Ichaka
AU  - Maiga Asmaou Kéita
AU  - Daou Adama
AU  - Diall Ilo Bella
AU  - Coulibaly Souleymane
AU  - Doumbia Coumba Thiam
AU  - Daffé Sanoussi
AU  - Sidibé Noumou
AU  - Sangaré Ibrahima
AU  - Millogo Georges Rosario Christian
AU  - Touré Mamadou
AU  - Sidibé Salimata
AU  - Diarra Mamadou Bocary
Y1  - 2015/07/04
PY  - 2015
N1  - https://doi.org/10.11648/j.sjcm.20150404.12
DO  - 10.11648/j.sjcm.20150404.12
T2  - Science Journal of Clinical Medicine
JF  - Science Journal of Clinical Medicine
JO  - Science Journal of Clinical Medicine
SP  - 76
EP  - 79
PB  - Science Publishing Group
SN  - 2327-2732
UR  - https://doi.org/10.11648/j.sjcm.20150404.12
AB  - Introduction: Hyperuricemia constitutes a risk for many organs and its prevalence is high ranging from 15-20% up to 35% in developing countries. HU relation to arterial hypertension was pointed out in the end of the XIX century and is recognized as independent cardiovascular risk factor. Thus HU is less studied in our environment which justifies our work to determine prevalence and with HU associated factors among hypertensive patients followed in the Cardiology department in the Mother Child Hospital “Le Luxembourg”. Methodology: It’s was a cross-sectional study in the Mother-Child Hospital “Le Luxembourg” in Bamako. All patients with complete labor tests were included making a sample of 51 hypertensive outpatients seen from July 2010 to January 2011. For any included patient, socio-demographic and biological variables were collected. In the same way a chest radiography, an ECG and an echocardiography were realized. Patients were asked about their knowledge about HU Hyperuricemia was defined as an uricemia > 420 μmol/l for men and 360 μmol/l for women. Microsoft Excel 2007 was used to gather data and SPSS version 12 to perform analyzes. Results: Mean age of the sample was 56,35 years, the sex-ratio Male: Female 0,76. Hyperuricemia, hypercreatininemia and hyperglycemia were found respectively in 66,7,33,3% and 23,5% of the cases. 78,4% of the patients had stated to have heard about hyperuricemia, 27,5% knew their hyperuricemia. The socio-demographic characteristics did not present a statistically significant difference. Conclusion: Hyperuricemia as a cardiovascular risk factor, had to be researched and managed more agressively. The very high proportion of patients with a hyperuricemia requires to detect it among hypertensive patients, to carry out an early treatment and thus to reduce the cardiovascular risk of the patient.
VL  - 4
IS  - 4
ER  - 

Copy | Download